Effects of Dexamethasone on Common Bile Duct Cannulation Time

Can Deep Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography Be Shortened by Dexamethasone

The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP.

Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.

Inclusion Criteria:

• Age: 18 years or above
• Both genders, male and female patients

Exclusion Criteria:

• Age younger than 18 years or below
• Pregnant females
• Pre existing stent in CBD or pancreatic duct
• Previous history of ERCP
• Patients with billroth II surgery
• Anatomical abnormalities
• Lack of competence in patients
• Roux en Y gastric bypass
• Patients with contra indications for steroids like DM